Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2018Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins
Gresch, G.; Schenke, L.; Mladenov, R.; Zwirner, S.; Cremer, C.; Niesen, J.; Grieger, E.; Brümmendorf, T.; Jost, E.; Fischer, R.; Stockmeyer, B.; Barth, S.; Nachreiner, T.; Stein, C.
Journal Article
2018Evaluation of different methods for determining the angle of attack on wind turbine blades with CFD results under axial inflow conditions
Rahimi, Hamid; Schepers, J. Gerard; Shen, W.Z.; Ramos Garcia, N.; Schneider, M.S.; Micallef, D.; Simao Ferreira, C.J.; Jost, E.; Kein, L.; Herráez, Iván
Journal Article
2018Evaluation of different methods of determining the angle of attack on wind turbine blades under yawed inflow conditions
Vimalakanthan, K.; Schepers, J. Gerard; Shen, W.Z.; Rahimi, Hamid; Micallef, D.; Simao Ferreira, C.J.; Jost, E.; Klein, L.
Conference Paper
2018Final results from the EU project AVATAR: Aerodynamic modelling of 10 MW wind turbines
Schepers, J. Gerard; Boorsma, K.; Sorensen, N.; Sieros, G.; Rahimi, Hamid; Heisselmann, H.; Jost, E.; Lutz, T.; Maeder, T.; Gonzalez, A.; Ferreira, C.; Stoevesandt, B.; Barakos, G.; Lampropoulos, N.; Croce, A.; Madsen, J.
Conference Paper
2016CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo
Mladenov, R.; Hristodorov, D.; Cremer, C.; Gresch, G.; Grieger, G.; Schenke, L.; Klose, D.; Amoury, M.; Woitok, M.; Jost, E.; Brümmerdorf, T.H.; Fendel, R.; Fischer, R.; Stein, C.; Thepen, T.; Barth, S.
Journal Article
2015The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia
Mladenov, R.; Hristodorov, D.; Cremer, C.; Hein, L.; Kreutzer, F.; Stroisch, T.; Niesen, J.; Brehm, H.; Blume, T.; Brummendorf, T.H.; Jost, E.; Thepen, T.; Fischer, R.; Stockmeyer, B.; Barth, S.; Stein, C.
Journal Article
2015Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo
Cremer, C.; Braun, H.; Mladenov, R.; Schenke, L.; Cong, X.; Jost, E.; Brümmendorf, T.H.; Fischer, R.; Carloni, P.; Barth, S.; Nachreiner, T.
Journal Article
2014Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins
Schiffer, S.; Rosinke, R.; Jost, E.; Hehmann-Titt, G.; Huhn, M.; Melmer, G.; Barth, S.; Thepen, T.
Journal Article
2013Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells
Schiffer, S.; Letzian, S.; Jost, E.; Mladenov, R.; Hristodorov, D.; Huhn, M.; Fischer, R.; Barth, S.; Thepen, T.
Journal Article
2011In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA in a human acute myeloid leukemia xenograft tumor model
Tur, M.K.; Huhn, M.; Jost, E.; Thepen, T.; Brümmendorf, T.H.; Barth, S.
Journal Article
2009Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in hodgkin lymphoma cells
Tur, M.K.; Neef, I.; Jost, E.; Galm, O.; Jäger, G.; Stöcker, M.; Ribbert, M.; Osieka, R.; Klinge, U.; Barth, S.
Journal Article
2008Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
Stahnke, B.; Thepen, T.; Stöcker, M.; Rosinke, R.; Jost, E.; Fischer, R.; Tur, M.K.; Barth, S.
Journal Article
2004m22(scFv)-ETA', a new recombinant anti-CD64 immunotoxin for specific elimination of AML cells
Tur, M.K.; Huhn, M.; Thepen, T.; Stöcker, M.; Krohn, R.; Vogel, S.; Jost, E.; Osieka, R.; Winkel, J.G. van de; Fischer, R.; Barth, S.
Journal Article
2003Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells
Tur, M.K.; Huhn, M.; Thepen, T.; Stocker, M.; Krohn, R.; Vogel, S.; Jost, E.; Osieka, R.; Winkel, J.G. van de; Fischer, R.; Finnern, R.; Barth, S.
Journal Article